Stay updated on FRα Clinical Trial: Mirvetuximab vs. Chemo

Sign up to get notified when there's something new on the FRα Clinical Trial: Mirvetuximab vs. Chemo page.
Latest website image capture
Clouds background image

Latest updates to the FRα Clinical Trial: Mirvetuximab vs. Chemo page

  1. Check
    5 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3. The page content remains the same.
    Difference
    0.0%
    Check dated 2026-03-12T00:47:51.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Fallopian tube cancer and Primary Peritoneal carcinoma to the study conditions, expanding the list of eligible diseases. The page revision is updated to v3.4.2 and the older funding notice has been removed.
    Difference
    0.2%
    Check dated 2026-02-11T14:21:06.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now displays a government funding status notice and updates the revision to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-04T10:25:24.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    New UI elements are introduced: a 'Show glossary' option, and additional metadata fields 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0' appear on the page. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and the earlier revision 'v3.3.4' are removed.
    Difference
    0.1%
    Check dated 2026-01-28T06:18:08.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    - Revision metadata updated: added Revision: v3.3.4 and removed Revision: v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-14T03:16:04.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Locations section replaced with a comprehensive new list of study sites across the US, Canada, and Europe. Old per-state location groupings were removed, and the page revision was updated to v3.3.3.
    Difference
    2%
    Check dated 2025-12-23T17:33:46.000Z thumbnail image

Stay in the know with updates to FRα Clinical Trial: Mirvetuximab vs. Chemo

Enter your email address, and we'll notify you when there's something new on the FRα Clinical Trial: Mirvetuximab vs. Chemo page.